TOMZ · TOMI Environmental Solutions, Inc.

The preliminary Q1 2026 results reflect strong sequential revenue growth of 67%, from an estimated $1.018 million in Q4 2025 to $1.7 million — a meaningful acceleration that management attributes to broad-based demand across multiple business lines. Revenue drivers included increased mobile equipment sales, custom integration deliverables (SIS, Hybrid, CES), repairs, and support services — indicating deeper customer engagement and utilization of TOMI’s installed base. Notably, the $440,000 annual purchase order for SteraMist iHP decontamination services with a global regenerative medicine leader marks a strategic shift from emergency response to contracted, recurring revenue — validating the scalability and reliability of the iHP Corporate Service offering. Standalone applicator sales surged 139% year-over-year, exceeding total 2025 volume, which strengthens the consumables-driven BIT™ model and suggests growing customer preference for flexible, on-demand disinfection solutions. The $5.3 million integrated projects pipeline — with $3.36 million already realized or committed via open orders — provides tangible near-term revenue visibility. While these are unaudited preliminary figures subject to customary adjustments, the breadth of growth across segments, the expansion of both product and service revenue streams, and the addition of a high-profile, multi-year service contract collectively signal improved commercial execution and increasing market validation for TOMI’s technology platform in mission-critical cleanroom and healthcare environments.